Methods And Apparatus For Treating Disorders Through Neurological And/Or Muscular Intervention

• US 20070106337A1
• Filed: 10/31/2006
• Published: 05/10/2007
• Est. Priority Date: 11/10/2005
• Status: Abandoned Application

• Current Assignee: electroCore, Inc.
• Original Assignee: electroCore, Inc.
• Inventors: Mendez, Steven, Ross, Arthur, Errico, Joseph, Pastena, James, Hu, Hecheng
• Application Number:
  US11/555,142
• Publication Number:
  US 20070106337A1
• Time in Patent Office: Days
• US Class Current: 607/40
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control
• CPC Class Codes: A61N 1/3601 of respiratory organs
• CPC Class Codes: A61N 1/36085 Eating disorders or obesity
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362

Abstract

Methods and apparatus proved for: simultaneously monitoring at least one of nerve and muscle electrical activity on respective sides of a target plexus of a patient; identifying desired electrical activity of at least one of nerves and muscles on both sides of the target plexus based on the monitored activity; and modulating the electrical activity of the at least one of nerves and muscles on both sides of the target plexus to achieve a therapeutic result.

Claims

1. A method, comprising:

simultaneously monitoring at least one of nerve and muscle electrical activity on respective sides of a target plexus of a patient;

identifying desired electrical activity of at least one of nerves and muscles on both sides of the target plexus based on the monitored activity; and

modulating the electrical activity of the at least one of nerves and muscles on both sides of the target plexus to achieve a therapeutic result.

2. The method of claim 1, wherein the modulation is accomplished using at least one of (i) electrical current to one or more electrodes, and (ii) pharmaceuticals.

3. The method of claim 1, wherein the target plexus is one of the great plexuses.

4. The method of claim 3, wherein the target plexus is the celiac plexus.

5. The method of claim 3, wherein the target plexus is the hepatic plexus.

6. The method of claim 4, wherein the monitoring and modulation of the at least one of nerves and muscles are performed on nerves of the sympathetic or parasympathetic nervous system on one side of the celiac plexus and one or more vagus nerves on the other side of the celiac plexus.

7. The method of claim 6, further comprising:

placing an electrode adjacent to or in communication with at least one ganglion along the sympathetic nerve chain and at least one of monitoring and modulating the at least one ganglion.

8. The method of claim 6, further comprising:

placing an electrode adjacent to or in communication with the celiac plexus and at least one of monitoring and modulating the plexus.

9. The method of claim 1, wherein the modulation is accomplished using electrical current to the one or more electrodes and the method further includes:

adjusting at least one parameter of one or more electrical signals to the electrodes until the physiological disorder has been demonstrably affected, modulated, treated, alleviated, arrested, or ameliorated.

10. The method of claim 1, wherein the step of modulating the electrical activity includes at least one of stimulating and reversibly blocking afferent or efferent signals of nervous and/or muscular tissue.

11. A method of treating obesity, comprising:

simultaneously monitoring electrical activity of at least two of;

(i) at least one of the greater and lesser splanchnic nerves of the sympathetic nervous system, (ii) at least one of the gastric and celiac branches of the vagus nerve, and (iii) the celiac plexus, of a patient;

identifying desired electrical activity of at least one of the monitored nerves on both sides of the celiac plexus based on the monitored activity; and

modulating the electrical activity of at least one of the monitored nerves on both sides of the celiac plexus to achieve a therapeutic result.

12. The method of claim 11, further comprising:

placing an electrode adjacent to or in communication with at least one ganglion along the sympathetic nerve chain and at least one of monitoring and modulating the at least one ganglion.

13. The method of claim 11, further comprising:

placing an electrode adjacent to or in communication with the celiac plexus and at least one of monitoring and modulating the plexus.

14. The method of claim 11, further comprising:

placing one or more electrodes adjacent to or in communication with one or more nerves of the greater and lesser splanchnic nerves and at least one of monitoring and modulating such nerves; and

placing one or more electrodes adjacent to or in communication with one or more nerves of the vagus nerve and at least one of monitoring and modulating such nerves.

15. The method of claim 14, further comprising placing the one or more electrodes adjacent to or in communication with one or more nerves and/or muscles of a stomach of the patient.

16. The method of claim 14, further comprising placing the one or more electrodes adjacent to or in communication with one or more nerves and/or muscles associated with a sphincter of a cardiac orifice of the patient.

17. The method of claim 11, wherein the step of modulating the electrical activity includes at least one of stimulating and reversibly blocking afferent or efferent signals of nervous and/or muscular tissue.

18. A method of treatment, comprising:

simultaneously monitoring electrical activity of at least two of;

(i) at least one nerve of the sympathetic nervous system, (ii) at least one nerve of the cranial nervous system, and (iii) at least one target plexus associated with the selected nerves of the sympathetic and cranial nervous systems, of a patient;

identifying desired electrical activity of at least one of the monitored nerves on both sides of the target plexus based on the monitored activity; and

modulating the electrical activity of at least one of the monitored nerves on both sides of the target plexus,

wherein the monitoring and modulating steps are directed to the treatment of one or more of;

hyperhydrosis, pain syndromes, intestinal motility disorders, sexual dysfunction, liver disorders, pancreas disorders, heart disorders, pulmonary disorders, gastrointestinal disorders, and biliary disorders.

19. The method of treatment of claim 18, comprising further simultaneously monitoring electrical activity of at least one of:

(i) muscles surrounding or interfacing with pathologically responding tissue, and (ii) any physical state of being that may be associated with the treatment.

20. The method of treatment of claim 18, further comprising creating a stimulation signal pattern based upon evaluation of the monitoring such that a desired therapeutic effect results.